Inozyme Pharma Inc. (INZY) - Insider Holders & Insider Ownership

List of insiders holdings for Inozyme Pharma Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner	2023-08-11 16:08:56	5,841,045 0	5,841,045	Form 13D
2	Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner	2024-02-20 19:11:01	4,280,308 0	4,280,308	Form 13D
3	Sonsini Peter W. 10% Owner	2020-07-28 18:30:55	0 2,437,689	2,437,689	Form 4
4	BASKETT FOREST 10% Owner	2020-07-28 18:26:52	0 2,437,689	2,437,689	Form 4
5	Florence Anthony A. Jr. 10% Owner	2020-07-28 18:27:42	0 2,437,689	2,437,689	Form 4
6	Makhzoumi Mohamad 10% Owner	2020-07-28 18:28:20	0 2,437,689	2,437,689	Form 4
7	MAKOWER JOSHUA 10% Owner	2020-07-28 18:29:09	0 2,437,689	2,437,689	Form 4
8	SANDELL SCOTT D 10% Owner	2020-07-28 18:29:54	0 2,437,689	2,437,689	Form 4
9	Novo Holdings A/S 10% Owner	2021-07-30 16:31:00	1,167,706 0	1,167,706	Form 13D
10	ALEXION PHARMACEUTICALS INC. 10% Owner	2020-07-28 18:11:09	1,109,910 0	1,109,910	Form 4
11	Sanofi 10% Owner	2020-07-29 06:06:37	0 520,125	520,125	Form 4
12	Braddock Demetrios 10% Owner	2020-07-23 21:19:08	404,142 0	404,142	Form 3
13	Schlessinger Joseph 10% Owner	2020-07-28 18:13:16	286,479 0	286,479	Form 4
14	Bjarke Henric Bjorn SVP, COO	2022-12-19 08:30:09	105,441 0	105,441	Form 4
15	Wenkert Deborah SVP, CMO	2021-02-04 17:11:58	100,000 0	100,000	Form 4
16	Harris Erik Director	2024-10-07 16:37:36	56,000 0	56,000	Form 4
17	Jungles Steven J SVP, CTO	2021-03-17 17:57:38	42,000 0	42,000	Form 4
18	Huertas Pedro SVP, CMO	2021-01-14 16:17:14	36,074 0	36,074	Form 4
19	Mathers Edward T Director	2024-06-20 16:30:03	28,000 0	28,000	Form 4
20	Edwards Martin Director	2024-06-20 16:07:25	28,000 0	28,000	Form 4
21	Bhagat Sarah M Director	2024-06-20 16:11:05	28,000 0	28,000	Form 4
22	DIAZ REINALDO M Director	2024-06-20 16:14:28	28,000 0	28,000	Form 4
23	DiPalma Stephen J. Interim CFO	2021-05-18 16:18:59	15,000 0	15,000	Form 4
24	Basso Stephen SVP Finance (PFO)	2021-03-25 16:05:22	13,000 0	13,000	Form 4
25	Inozyme Pharma Inc. Director	2021-06-24 16:10:00	9,367 0	9,367	Form 4
26	Subramanian Sanjay SVP, CFO & Head of BD	2025-07-03 19:16:07	0 0	0	Form 4
27	Treco Douglas A CEO & Chairman	2025-07-03 19:03:04	0 0	0	Form 4
28	Sullivan Lynne Marie Director	2025-07-03 19:04:53	0 0	0	Form 4
29	Bolte Axel Director	2025-07-03 19:07:07	0 0	0	Form 4
30	Winton Matthew COO	2025-07-03 19:08:49	0 0	0	Form 4
31	Hopfner Robert Lorne Director	2025-07-03 18:59:42	0 0	0	Form 4
32	Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director	2025-08-27 17:42:28	0 0	0	Form 13D
33	New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC 10% Owner	2024-02-14 18:08:47	0 0	0	Form 13G
34	Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner	2025-08-13 16:31:52	0 0	0	Form 13G
35	RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner	2021-11-15 16:35:14	0 0	0	Form 13G